The website does not constitute a distribution, an offer or solicitation of an offer to buy or sell any interest in any securities or other investment product managed or arranged by Chartwell Capital Limited (H.K.) or any of its affiliates. The information contained herein is current as at the date of publication and is subject to change without any notice. No representation or warranty, expressed or implied, is made to the accuracy, completeness or thoroughness of the contents, and no liability whatsoever is accepted by Chartwell Capital Limited (H.K.) or any of its affiliates. The material contained herein may not be reproduced, distributed or published without the prior consent of Chartwell Capital Limited (H.K.). If you are in any doubt about any of the information contained herein you should consult your own investment advisor, lawyer, accountant or other professional advisers.
By clicking proceed, I declare that I reside outside Hong Kong or at a location in Hong Kong but am a professional investor.
While the world is excited about a COVID-19 vaccine, we can dare to think about the “new normal” in a post-pandemic economy. Hong Kong tourism has been particularly hard hit by the city’s social unrest and the pandemic. As it evolves in the wake of this perfect storm, Chartwell’s Ronald Chan shares his opinion on the potential opportunity in high-end medical tourism. Click the link below for reading the original article.